{"id":"W3161615669","doi":"10.1038/s41467-021-23152-6","title":"Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity","year":2021,"lang":"en","type":"article","venue":"Nature Communications","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Center for Scientific Review; Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institute of General Medical Sciences; National Institute on Aging; Michigan Technology Tri-Corridor; National Cancer Institute; University of Toronto; National Institutes of Health; U.S. Department of Health and Human Services; Michigan Economic Development Corporation; National Institute of Diabetes and Digestive and Kidney Diseases; Office of Science; University of Michigan; Leukemia and Lymphoma Society; National Heart, Lung, and Blood Institute; Argonne National Laboratory; U.S. Department of Energy","keywords":"Druggability; Chemistry; Histone methyltransferase; Small molecule; Drug discovery; Leukemia; Cell biology; Computational biology; Cancer research; Biology; Biochemistry; Epigenetics; Gene; Genetics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000256344,0.0007359543,0.0004543993,0.0003994731,0.0001893029,0.0004157507,0.0004947133,0.0003359822,0.001713593],"category_scores_gemma":[0.0001546732,0.0002292766,0.0003459647,0.000230731,0.000235974,0.0002856933,0.0003146833,0.0007802277,0.0004589407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004599454,"about_ca_system_score_gemma":0.0004247724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003872795,"about_ca_topic_score_gemma":0.001966226,"domain_scores_codex":[0.9999065,0.00001369057,0.00000469878,0.000014998,0.00002840719,0.00003177849],"domain_scores_gemma":[0.9999352,0.000009395593,0.00001577503,0.000005288132,0.00001346266,0.00002099418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000705718,0.001016909,0.0007567581,0.0003973152,0.0001119429,0.0003841773,0.00006534693,0.003669923,0.9286133,0.001825513,0.002240871,0.06021232],"study_design_scores_gemma":[0.001076264,0.00752061,0.003105339,0.00004914599,0.0001554796,0.001153531,0.00003518941,0.007662585,0.9470538,0.0005439932,0.03160046,0.00004362889],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9277561,0.02102163,0.03184638,0.001156066,0.0002484246,0.001112411,0.002253425,0.0008735764,0.01373202],"genre_scores_gemma":[0.9586883,0.01342191,0.01493101,0.0004851628,0.00005081939,0.0002461524,0.002254026,0.00005810053,0.009864487],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001713593,"threshold_uncertainty_score":0.005732596,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01001106999974645,"score_gpt":0.2772316053937022,"score_spread":0.2672205353939557,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}